维普中文期刊产品整合服务
35篇 您的检索式:作者名="Z Panagi"
    题名 作者 年代 出处 被引量
1PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties 显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Controlled Release2002,79,:1
2Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied m PEG content显示文摘Li M Panagi Z Avgoustakis K 2012Int J Nanomedicine2012,7,5:1
3Effect of composition on the physicochemical characteristics,in vitro stability,and bio-distribution of PLGA-mPEG nanoparticles显示文摘Avgoustakis K Beletsi A Panagi Z 2003Int J Pharm2003,259,12:1
4Effect of copolymer composition on the physicochemical charaetelistics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles 显示文摘AVGOUSTAKIS K BELETSI A PANAGI Z 2003Int J Pharm2003,259,1:1
5PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Control Release2002,79,:1
6PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties 显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Control Release2002,79,13:1
7Transutaneous delivery of a nanoencapsulated antigen: inductian of immune responses显示文摘MATTHEOLABAKIS G LAGOUMINTZIS G PANAGI Z 2010Int J Pharm2010,385,12:1
8PLGA-mPEG nanoparticles of cisplatin:in vitro nanoparticle degradation,in vitro drug release and in vivo drug residence in blood properties显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Control Release2002,79,13:1
9PLGA-mPEG nanoparticles of displatin;in vitro nanoparticle degradation , in vitro drug release and in vivo drug residence in blood properties显示文摘Avgustakis K Beletai A Panagi Z 2002J Controlled Release2002,79,13:1
10Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles显示文摘Panagi Z Beletsi A Evangelatos G 2001Int J Pharm2001,221,12:1
11PLA and PLGA microspheres of β-galactosidase: Effect of formulation factors on protein antigenicity and immunogenicity显示文摘Stivaktakis N Nikou K Panagi Z etal 2004J Biomed Mater Res Part A2004,70,:1
12PLGA-mPEG nanoparticles of cisplatin:in vitro nanoparticle degradation,in vitro drug release and in vivo drug residence in blood properties显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Control Bel2002,79,:1
13Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-Mpeg nanoparticles 显示文摘K Avgoustakis A Beletsi Z Panagi 2003Int J Pharm2003,259,:1
14Effect of composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA - mPEG nanoparticles 显示文摘Avgoustakis K Beletsi A Panagi Z 2003Int J Pharm2003,259,12:1
15PLGA-nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Control Release2002,79,13:1
16Effect of copolymer composition on the physieochemical characteristics,in vitro stability,and biodistribution of PLGA-mPEG nanoparticles显示文摘Avgoustakis K Beletsi A Panagi Z 2003Int J Pharm2003,259,12:1
17PLGA-mPEG nanoparticles of cisplat in:in vitro nanoparticle degradation,in vitro drug release and in vivo drug residence in blood properties显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Control Release2002,79,13:1
18Effect of dose on the biodistribution and phar acokinetics of PLGA and PLGA-mPEG nanoparticles显示文摘Panagi Z Avgoustkis K Evangelatos G 2001lnt J Pharm2001,221,:1
19显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Controlled Rel2002,79,:1
20PLGA - mPEG nano- particles of cisplatin : in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties 显示文摘Avgoustakis K Beletsi A Panagi Z 2002J Control Release2002,79,13:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费